A novel BMP2-coprecipitated, layer-by-layer assembled biomimetic calcium phosphate particle: a biodegradable and highly efficient osteoinducer.

PURPOSE To repair large-size bone defects, most bone-defect-filling materials in clinic need to obtain osteoinductivity either by mixing them with particulate autologous bone or adsorbing bone morphogenetic protein 2 (BMP2). However, both approaches encounter various limitations. In this study, we hypothesized that our novel particles of biomimetic BMP2-coprecipitated calcium phosphate (BMP2-cop.BioCaP) could serve as an independent and biodegradable osteoinducer to induce bone formation efficiently for these bone-defect-filling materials, for example, deproteinized bovine bone (DBB). MATERIALS AND METHODS We alternately layer-by-layer assembled amorphous and crystalline CaP triply to enable a "bamboo-like" growth of the particles. We functionalized BioCaP by coprecipitating BMP2 into the most outer layer of BioCaP. We monitored the degradation, osteoinductivity, and foreign-body reaction of either BMP2-cop.BioCaP or its combination with DBB in an ectopic site in rats. RESULTS After 5 weeks, the BMP2-cop.BioCaP significantly induced new bone formation not only alone but also when mixed with DBB. Its osteoinductive efficiency was 10-fold higher than the adsorbed BMP2. Furthermore, BMP2-cop.BioCaP also reduced significantly the host foreign-body reaction to DBB in comparison with the adsorbed BMP2. After a 5-week implantation, more than 90% of BMP2-cop.BioCaP degraded. CONCLUSIONS These findings indicate a promising clinical potential for BMP2-cop.BioCaP in the repair of large-size bone defects.

[1]  S. Bose,et al.  Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering: a review. , 2012, Acta biomaterialia.

[2]  T. Kawai,et al.  Granule size-dependent bone regenerative capacity of octacalcium phosphate in collagen matrix. , 2012, Tissue engineering. Part A.

[3]  E. Hunziker,et al.  Functionalization of deproteinized bovine bone with a coating-incorporated depot of BMP-2 renders the material efficiently osteoinductive and suppresses foreign-body reactivity. , 2011, Bone.

[4]  K. de Groot,et al.  Biomimetic coatings for bone tissue engineering of critical-sized defects , 2010, Journal of The Royal Society Interface.

[5]  E. Hunziker,et al.  The effect of a slow mode of BMP-2 delivery on the inflammatory response provoked by bone-defect-filling polymeric scaffolds. , 2010, Biomaterials.

[6]  E. Hunziker,et al.  Biomimetic coating of organic polymers with a protein-functionalized layer of calcium phosphate: the surface properties of the carrier influence neither the coating characteristics nor the incorporation mechanism or release kinetics of the protein. , 2010, Tissue engineering. Part C, Methods.

[7]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.

[8]  Maryam Tabrizian,et al.  Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering , 2009, Biotechnology Letters.

[9]  Jin-Woo Park,et al.  Bone formation with various bone graft substitutes in critical-sized rat calvarial defect. , 2009, Clinical oral implants research.

[10]  J. M. Badura,et al.  Short-term Osteoclastic Activity Induced by Locally High Concentrations of Recombinant Human Bone Morphogenetic Protein–2 in a Cancellous Bone Environment , 2009, Spine.

[11]  K. Marra,et al.  Bone Morphogenetic Protein 2 Therapy for Craniofacial Surgery , 2008, The Journal of craniofacial surgery.

[12]  F. Schwarz,et al.  Lateral ridge augmentation using particulated or block bone substitutes biocoated with rhGDF-5 and rhBMP-2: an immunohistochemical study in dogs. , 2008, Clinical oral implants research.

[13]  Charles A Powell,et al.  Foreign Body Reaction to Anorganic Bovine Bone and Autogenous Bone With Platelet‐Rich Plasma in Guided Bone Regeneration , 2008 .

[14]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[15]  E. Hunziker,et al.  The influence of BMP-2 and its mode of delivery on the osteoconductivity of implant surfaces during the early phase of osseointegration. , 2007, Biomaterials.

[16]  K. Shakesheff,et al.  Polymer carriers for drug delivery in tissue engineering. , 2007, Advanced drug delivery reviews.

[17]  E. Hunziker,et al.  Delivery Mode and Efficacy of BMP-2 in Association with Implants , 2007, Journal of dental research.

[18]  S. Glassman,et al.  Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.

[19]  B. Ratner,et al.  The role of osteopontin in foreign body giant cell formation. , 2005, Biomaterials.

[20]  E. Hunziker,et al.  BMP-2 liberated from biomimetic implant coatings induces and sustains direct ossification in an ectopic rat model. , 2005, Bone.

[21]  Zhuoran Zhao,et al.  Combinatorial gene therapy for bone regeneration: Cooperative interactions between adenovirus vectors expressing bone morphogenetic proteins 2, 4, and 7 , 2005, Journal of cellular biochemistry.

[22]  Buddy D Ratner,et al.  Biomaterials: where we have been and where we are going. , 2004, Annual review of biomedical engineering.

[23]  Pierre Layrolle,et al.  Bone morphogenetic protein 2 incorporated into biomimetic coatings retains its biological activity. , 2004, Tissue engineering.

[24]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[25]  D. Kohn,et al.  Effects of pH on human bone marrow stromal cells in vitro: implications for tissue engineering of bone. , 2002, Journal of biomedical materials research.

[26]  G Pradal,et al.  Cellular mechanisms of calcium phosphate ceramic degradation. , 1999, Histology and histopathology.

[27]  J. Lou,et al.  Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[28]  T. Kokubo,et al.  Differences of bone bonding ability and degradation behaviour in vivo between amorphous calcium phosphate and highly crystalline hydroxyapatite coating. , 1996, Biomaterials.

[29]  E R Weibel,et al.  Recent stereological methods for cell biology: a brief survey. , 1990, The American journal of physiology.

[30]  H J Gundersen,et al.  The efficiency of systematic sampling in stereology and its prediction * , 1987, Journal of microscopy.

[31]  T. N. Salthouse,et al.  Some aspects of macrophage behavior at the implant interface. , 1984, Journal of biomedical materials research.

[32]  B. D. de Lumen,et al.  Fluorescein-hemoglobin as a substrate for cathepsin D and other proteases. , 1970, Analytical biochemistry.

[33]  J. Lindhe,et al.  Socket grafting with the use of autologous bone: an experimental study in the dog. , 2011, Clinical oral implants research.

[34]  P. Schlesinger,et al.  Calcium signalling and calcium transport in bone disease. , 2007, Sub-cellular biochemistry.

[35]  J. Granjeiro,et al.  Rat subcutaneous tissue response to macrogranular porous anorganic bovine bone graft. , 2006, Brazilian dental journal.

[36]  E. Bonucci,et al.  Tartrate-resistant acid phosphate activity as osteoclastic marker: Sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry , 2005, Osteoporosis International.